| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.846 | 0.005 | 0.846 | Analgesic | 0.832 0.005 DBMET02688 0.761 0.008 DBMET02689 0.782 0.007 DBMET02690 0.798 0.006 DBMET02691 0.798 0.006 DBMET02693 0.695 0.014 DBMET02692 0.795 0.006 DBMET02694 | ||
| 0.681 | 0.004 | 0.707 | Anesthetic general | 0.494 0.008 DBMET02688 0.703 0.003 DBMET02689 0.55 0.005 DBMET02690 0.707 0.003 DBMET02691 0.656 0.004 DBMET02693 0.685 0.004 DBMET02692 0.683 0.004 DBMET02694 | DBMET02691 | |
| 0.67 | 0.004 | 0.67 | Sigma receptor antagonist | 0.301 0.006 DBMET02688 0.444 0.005 DBMET02689 0.517 0.004 DBMET02690 0.549 0.004 DBMET02691 0.556 0.004 DBMET02693 0.415 0.005 DBMET02692 0.465 0.004 DBMET02694 | ||
| 0.618 | 0.006 | 0.618 | Potassium channel (Voltage-sensitive) blocker | 0.33 0.041 DBMET02688 0.416 0.024 DBMET02689 0.493 0.015 DBMET02690 0.433 0.022 DBMET02691 0.531 0.012 DBMET02693 0.31 0.046 DBMET02692 0.376 0.031 DBMET02694 | ||
| 0.598 | 0.004 | 0.598 | Analgesic, opioid | 0.547 0.004 DBMET02688 0.493 0.004 DBMET02689 0.464 0.004 DBMET02690 0.564 0.004 DBMET02691 0.518 0.004 DBMET02693 0.43 0.004 DBMET02692 0.548 0.004 DBMET02694 | ||
| 0.594 | 0.008 | 0.594 | HERG channel blocker | 0.273 0.057 DBMET02688 0.399 0.028 DBMET02689 0.442 0.021 DBMET02690 0.383 0.031 DBMET02691 0.495 0.016 DBMET02693 0.257 0.063 DBMET02692 0.351 0.037 DBMET02694 | ||
| 0.588 | 0.014 | 0.782 | Spasmolytic | 0.381 0.044 DBMET02688 0.651 0.009 DBMET02689 0.782 0.004 DBMET02690 0.626 0.011 DBMET02691 0.604 0.013 DBMET02693 0.67 0.008 DBMET02692 0.59 0.014 DBMET02694 | DBMET02690 | |
| 0.537 | 0.004 | 0.759 | Anesthetic local | 0.359 0.008 DBMET02688 0.538 0.004 DBMET02689 0.759 0.003 DBMET02690 0.491 0.004 DBMET02691 0.472 0.005 DBMET02693 0.501 0.004 DBMET02692 0.276 0.015 DBMET02694 | DBMET02690 | |
| 0.504 | 0.011 | 0.621 | Potassium channel blocker | 0.26 0.062 DBMET02688 0.264 0.06 DBMET02689 0.621 0.005 DBMET02690 0.326 0.039 DBMET02691 0.412 0.02 DBMET02693 0.236 0.073 DBMET02692 0.243 0.07 DBMET02694 | DBMET02690 | |
| 0.471 | 0.012 | 0.471 | Sigma receptor agonist | 0.36 0.028 DBMET02689 0.448 0.015 DBMET02691 0.393 0.023 DBMET02693 0.421 0.019 DBMET02692 0.378 0.025 DBMET02694 | ||
| 0.47 | 0.032 | 0.645 | 5 Hydroxytryptamine release stimulant | 0.645 0.011 DBMET02688 0.584 0.016 DBMET02689 0.234 0.097 DBMET02690 0.484 0.03 DBMET02691 0.184 0.137 DBMET02693 0.363 0.054 DBMET02692 0.176 0.145 DBMET02694 | DBMET02688 | |
| 0.419 | 0.004 | 0.424 | Opioid antagonist | 0.313 0.005 DBMET02688 0.289 0.005 DBMET02689 0.253 0.008 DBMET02690 0.424 0.004 DBMET02691 0.316 0.005 DBMET02693 0.264 0.007 DBMET02692 0.351 0.005 DBMET02694 | DBMET02691 | |
| 0.395 | 0.004 | 0.399 | Opioid mu receptor antagonist | 0.296 0.005 DBMET02688 0.266 0.005 DBMET02689 0.237 0.006 DBMET02690 0.399 0.004 DBMET02691 0.296 0.005 DBMET02693 0.24 0.006 DBMET02692 0.331 0.005 DBMET02694 | DBMET02691 | |
| 0.389 | 0.004 | 0.389 | Opioid mu receptor agonist | 0.329 0.004 DBMET02688 0.254 0.004 DBMET02689 0.243 0.004 DBMET02690 0.378 0.004 DBMET02691 0.296 0.004 DBMET02693 0.236 0.004 DBMET02692 0.334 0.004 DBMET02694 | ||
| 0.374 | 0.005 | 0.417 | Neurotrophic factor | 0.253 0.012 DBMET02688 0.258 0.011 DBMET02689 0.417 0.005 DBMET02690 0.323 0.007 DBMET02691 0.395 0.005 DBMET02693 0.302 0.008 DBMET02692 0.312 0.007 DBMET02694 | DBMET02690 | |
| 0.369 | 0.004 | 0.369 | Opioid agonist | 0.327 0.004 DBMET02688 0.251 0.005 DBMET02689 0.204 0.005 DBMET02690 0.353 0.004 DBMET02691 0.267 0.005 DBMET02693 0.203 0.005 DBMET02692 0.303 0.004 DBMET02694 | ||
| 0.348 | 0.003 | 0.348 | Acetylcholine release stimulant | 0.183 0.005 DBMET02688 0.167 0.009 DBMET02689 0.175 0.007 DBMET02690 0.235 0.004 DBMET02691 0.319 0.003 DBMET02693 0.251 0.004 DBMET02692 0.204 0.005 DBMET02694 | ||
| 0.349 | 0.006 | 0.42 | Acetylcholine muscarinic antagonist | 0.248 0.015 DBMET02688 0.232 0.018 DBMET02689 0.42 0.005 DBMET02690 0.35 0.006 DBMET02691 0.351 0.006 DBMET02693 0.26 0.013 DBMET02692 0.26 0.013 DBMET02694 | DBMET02690 | |
| 0.336 | 0.004 | 0.336 | Acetylcholine M2 receptor antagonist | 0.227 0.005 DBMET02688 0.156 0.01 DBMET02689 0.335 0.004 DBMET02690 0.303 0.004 DBMET02691 0.265 0.005 DBMET02693 0.162 0.01 DBMET02692 0.149 0.011 DBMET02694 | ||
| 0.334 | 0.005 | 0.334 | Calcium channel (voltage-sensitive) blocker | 0.172 0.024 DBMET02688 0.301 0.006 DBMET02689 0.104 0.079 DBMET02690 0.21 0.015 DBMET02691 0.23 0.012 DBMET02693 0.193 0.019 DBMET02692 0.192 0.019 DBMET02694 | ||
| 0.336 | 0.007 | 0.336 | Calcium channel blocker | 0.207 0.027 DBMET02688 0.322 0.008 DBMET02689 0.195 0.032 DBMET02690 0.236 0.019 DBMET02691 0.265 0.014 DBMET02693 0.245 0.018 DBMET02692 0.199 0.03 DBMET02694 | ||
| 0.331 | 0.01 | 0.331 | Neuropeptide Y2 antagonist | 0.315 0.014 DBMET02688 0.313 0.014 DBMET02689 0.319 0.013 DBMET02690 0.331 0.011 DBMET02691 0.308 0.016 DBMET02693 0.291 0.023 DBMET02692 0.318 0.013 DBMET02694 | ||
| 0.31 | 0.005 | 0.322 | Opioid kappa receptor antagonist | 0.205 0.01 DBMET02688 0.212 0.009 DBMET02689 0.205 0.01 DBMET02690 0.322 0.005 DBMET02691 0.235 0.008 DBMET02693 0.22 0.009 DBMET02692 0.249 0.007 DBMET02694 | DBMET02691 | |
| 0.34 | 0.042 | 0.44 | Cardiotonic | 0.186 0.133 DBMET02688 0.41 0.027 DBMET02689 0.44 0.022 DBMET02690 0.282 0.064 DBMET02691 0.304 0.054 DBMET02693 0.287 0.062 DBMET02692 0.284 0.063 DBMET02694 | DBMET02690 | |
| 0.315 | 0.026 | 0.357 | P-glycoprotein inhibitor | 0.32 0.025 DBMET02689 0.195 0.067 DBMET02690 0.292 0.03 DBMET02691 0.324 0.025 DBMET02693 0.357 0.02 DBMET02692 0.297 0.03 DBMET02694 | DBMET02692 | |
| 0.3 | 0.014 | 0.404 | Cholinergic antagonist | 0.25 0.021 DBMET02688 0.167 0.044 DBMET02689 0.404 0.008 DBMET02690 0.283 0.016 DBMET02691 0.303 0.014 DBMET02693 0.205 0.031 DBMET02692 0.224 0.026 DBMET02694 | DBMET02690 | |
| 0.289 | 0.004 | 0.332 | Acetylcholine M3 receptor antagonist | 0.191 0.007 DBMET02688 0.186 0.008 DBMET02689 0.318 0.004 DBMET02690 0.332 0.004 DBMET02691 0.304 0.004 DBMET02693 0.225 0.005 DBMET02692 0.204 0.006 DBMET02694 | DBMET02691 | |
| 0.296 | 0.014 | 0.401 | Acetylcholine antagonist | 0.248 0.02 DBMET02688 0.162 0.044 DBMET02689 0.401 0.008 DBMET02690 0.279 0.016 DBMET02691 0.297 0.014 DBMET02693 0.203 0.03 DBMET02692 0.218 0.026 DBMET02694 | DBMET02690 | |
| 0.253 | 0.005 | 0.271 | Opioid delta receptor antagonist | 0.219 0.009 DBMET02688 0.197 0.011 DBMET02689 0.184 0.014 DBMET02690 0.271 0.005 DBMET02691 0.205 0.01 DBMET02693 0.195 0.012 DBMET02692 0.232 0.007 DBMET02694 | DBMET02691 | |
| 0.255 | 0.008 | 0.255 | Calcium channel N-type blocker | 0.201 0.016 DBMET02688 0.236 0.01 DBMET02689 0.118 0.066 DBMET02690 0.175 0.024 DBMET02691 0.192 0.018 DBMET02693 0.148 0.039 DBMET02692 0.157 0.034 DBMET02694 | ||
| 0.281 | 0.047 | 0.328 | Gastrin inhibitor | 0.28 0.048 DBMET02688 0.265 0.062 DBMET02689 0.229 0.106 DBMET02690 0.233 0.101 DBMET02691 0.289 0.041 DBMET02693 0.328 0.017 DBMET02694 | DBMET02694 | |
| 0.245 | 0.023 | 0.245 | Nav1.2 sodium channel blocker | 0.158 0.052 DBMET02688 0.186 0.04 DBMET02689 0.124 0.079 DBMET02690 0.199 0.035 DBMET02691 0.213 0.03 DBMET02693 0.134 0.068 DBMET02692 0.11 0.096 DBMET02694 | ||
| 0.27 | 0.054 | 0.27 | 5 Hydroxytryptamine 1E antagonist | 0.23 0.096 DBMET02688 0.262 0.062 DBMET02691 0.247 0.078 DBMET02692 | ||
| 0.21 | 0.004 | 0.228 | Opioid delta receptor agonist | 0.228 0.004 DBMET02688 0.114 0.005 DBMET02689 0.087 0.006 DBMET02690 0.215 0.004 DBMET02691 0.115 0.005 DBMET02693 0.099 0.005 DBMET02692 0.143 0.005 DBMET02694 | DBMET02688 | |
| 0.262 | 0.057 | 0.325 | Tyrosine 3 hydroxylase inhibitor | 0.309 0.029 DBMET02688 0.21 0.118 DBMET02689 0.199 0.138 DBMET02690 0.325 0.023 DBMET02691 0.229 0.091 DBMET02693 0.283 0.042 DBMET02692 0.323 0.024 DBMET02694 | DBMET02691 | |
| 0.245 | 0.041 | 0.304 | Neurotrophic factor enhancer | 0.222 0.057 DBMET02689 0.158 0.126 DBMET02690 0.3 0.018 DBMET02691 0.235 0.048 DBMET02693 0.304 0.017 DBMET02692 0.216 0.062 DBMET02694 | DBMET02692 | |
| 0.291 | 0.095 | 0.373 | Vasodilator, coronary | 0.25 0.135 DBMET02688 0.295 0.092 DBMET02689 0.312 0.078 DBMET02690 0.297 0.09 DBMET02691 0.322 0.071 DBMET02693 0.373 0.045 DBMET02692 0.26 0.125 DBMET02694 | DBMET02692 | |
| 0.199 | 0.003 | 0.261 | Sphingosine kinase inhibitor | 0.136 0.004 DBMET02688 0.19 0.003 DBMET02689 0.092 0.01 DBMET02690 0.221 0.003 DBMET02691 0.261 0.003 DBMET02693 0.156 0.004 DBMET02692 0.117 0.005 DBMET02694 | DBMET02693 | |
| 0.195 | 0.01 | 0.195 | 5 Hydroxytryptamine 1F antagonist | 0.116 0.025 DBMET02688 0.094 0.034 DBMET02689 0.127 0.021 DBMET02691 0.11 0.027 DBMET02693 0.098 0.032 DBMET02692 0.106 0.029 DBMET02694 | ||
| 0.263 | 0.082 | 0.263 | Ca(v)3.3 blocker | 0.206 0.179 DBMET02691 0.221 0.15 DBMET02693 0.218 0.155 DBMET02692 | ||
| 0.341 | 0.161 | 0.388 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.388 0.111 DBMET02688 0.278 0.244 DBMET02690 | DBMET02688 | |
| 0.192 | 0.015 | 0.192 | Neuropeptide Y antagonist | 0.166 0.019 DBMET02688 0.167 0.019 DBMET02690 0.129 0.027 DBMET02691 0.08 0.058 DBMET02693 | ||
| 0.209 | 0.038 | 0.272 | Acetylcholine M1 receptor antagonist | 0.164 0.063 DBMET02688 0.139 0.086 DBMET02689 0.272 0.02 DBMET02690 0.207 0.039 DBMET02691 0.195 0.044 DBMET02693 0.147 0.077 DBMET02692 0.146 0.078 DBMET02694 | DBMET02690 | |
| 0.178 | 0.008 | 0.229 | Dopamine uptake inhibitor | 0.148 0.01 DBMET02688 0.123 0.014 DBMET02689 0.229 0.005 DBMET02690 0.134 0.012 DBMET02691 0.139 0.011 DBMET02693 0.086 0.023 DBMET02692 0.087 0.023 DBMET02694 | DBMET02690 | |
| 0.184 | 0.014 | 0.185 | Multidrug resistance-associated protein 1 inhibitor | 0.134 0.035 DBMET02689 0.171 0.017 DBMET02691 0.171 0.017 DBMET02693 0.185 0.014 DBMET02692 0.173 0.017 DBMET02694 | DBMET02692 | |
| 0.194 | 0.026 | 0.194 | Nav1.3 sodium channel blocker | 0.137 0.057 DBMET02688 0.182 0.031 DBMET02689 0.127 0.067 DBMET02690 0.145 0.051 DBMET02691 0.158 0.043 DBMET02693 0.106 0.091 DBMET02692 | ||
| 0.18 | 0.012 | 0.18 | 5 Hydroxytryptamine 1 agonist | 0.049 0.038 DBMET02688 0.074 0.027 DBMET02689 0.076 0.026 DBMET02691 0.109 0.019 DBMET02693 0.047 0.039 DBMET02692 0.047 0.039 DBMET02694 | ||
| 0.165 | 0.003 | 0.226 | Sphingosine kinase 1 inhibitor | 0.111 0.004 DBMET02688 0.163 0.003 DBMET02689 0.065 0.008 DBMET02690 0.164 0.003 DBMET02691 0.226 0.002 DBMET02693 0.11 0.004 DBMET02692 0.075 0.005 DBMET02694 | DBMET02693 | |
| 0.162 | 0.004 | 0.179 | CC chemokine 5 receptor agonist | 0.128 0.006 DBMET02688 0.127 0.006 DBMET02689 0.104 0.018 DBMET02690 0.179 0.003 DBMET02691 0.123 0.007 DBMET02693 0.112 0.012 DBMET02692 0.132 0.005 DBMET02694 | DBMET02691 | |
| 0.242 | 0.085 | 0.321 | Interleukin agonist | 0.321 0.039 DBMET02688 0.28 0.059 DBMET02689 0.315 0.041 DBMET02690 0.231 0.093 DBMET02691 0.235 0.09 DBMET02693 0.226 0.097 DBMET02692 0.3 0.048 DBMET02694 | DBMET02688 | |
| 0.164 | 0.014 | 0.191 | 5 Hydroxytryptamine uptake inhibitor | 0.191 0.012 DBMET02688 0.094 0.028 DBMET02689 0.16 0.014 DBMET02690 0.095 0.028 DBMET02691 0.114 0.022 DBMET02693 0.066 0.042 DBMET02692 0.077 0.035 DBMET02694 | DBMET02688 | |
| 0.239 | 0.092 | 0.392 | 5 Hydroxytryptamine uptake stimulant | 0.392 0.016 DBMET02688 0.235 0.097 DBMET02691 0.265 0.067 DBMET02692 0.239 0.092 DBMET02694 | DBMET02688 | |
| 0.171 | 0.024 | 0.186 | Alpha 2c adrenoreceptor antagonist | 0.109 0.058 DBMET02688 0.15 0.032 DBMET02691 0.085 0.081 DBMET02693 0.186 0.021 DBMET02692 | DBMET02692 | |
| 0.218 | 0.071 | 0.242 | Psychostimulant | 0.242 0.061 DBMET02688 0.177 0.095 DBMET02690 0.205 0.077 DBMET02691 0.196 0.082 DBMET02693 0.184 0.09 DBMET02692 0.242 0.061 DBMET02694 | DBMET02694 | |
| 0.17 | 0.026 | 0.183 | Nav1.1 sodium channel blocker | 0.183 0.023 DBMET02689 0.106 0.059 DBMET02690 0.164 0.028 DBMET02691 0.164 0.028 DBMET02693 0.121 0.047 DBMET02692 0.113 0.054 DBMET02694 | DBMET02689 | |
| 0.165 | 0.027 | 0.179 | Chemokine receptor antagonist | 0.142 0.036 DBMET02688 0.179 0.023 DBMET02690 0.114 0.052 DBMET02691 0.114 0.052 DBMET02693 0.107 0.057 DBMET02694 | DBMET02690 | |
| 0.315 | 0.178 | 0.484 | Caspase 9 stimulant | 0.291 0.204 DBMET02688 0.378 0.125 DBMET02691 0.26 0.241 DBMET02693 0.484 0.066 DBMET02692 0.312 0.181 DBMET02694 | DBMET02692 | |
| 0.173 | 0.036 | 0.177 | Neuropeptide Y1 antagonist | 0.156 0.057 DBMET02688 0.14 0.081 DBMET02689 0.177 0.032 DBMET02691 0.148 0.068 DBMET02693 0.149 0.066 DBMET02692 0.154 0.059 DBMET02694 | DBMET02691 | |
| 0.158 | 0.03 | 0.158 | Antihistaminic | 0.113 0.046 DBMET02693 | ||
| 0.15 | 0.024 | 0.15 | Histamine H1 receptor antagonist | 0.087 0.051 DBMET02691 0.11 0.036 DBMET02693 0.13 0.029 DBMET02694 | ||
| 0.134 | 0.01 | 0.134 | Viral attachment inhibitor | 0.13 0.011 DBMET02688 0.089 0.034 DBMET02689 0.087 0.038 DBMET02690 0.105 0.021 DBMET02691 0.11 0.018 DBMET02693 0.088 0.035 DBMET02692 0.104 0.021 DBMET02694 | ||
| 0.134 | 0.015 | 0.134 | 5 Hydroxytryptamine 1B antagonist | 0.078 0.036 DBMET02688 0.08 0.034 DBMET02691 0.073 0.038 DBMET02693 | ||
| 0.149 | 0.03 | 0.149 | Histamine antagonist | 0.101 0.047 DBMET02693 | ||
| 0.176 | 0.059 | 0.231 | Death-associated protein kinase 2 inhibitor | 0.231 0.018 DBMET02688 0.152 0.102 DBMET02690 0.183 0.051 DBMET02691 0.179 0.055 DBMET02692 | DBMET02688 | |
| 0.161 | 0.045 | 0.161 | 5 Hydroxytryptamine antagonist | 0.095 0.083 DBMET02688 0.092 0.086 DBMET02693 | ||
| 0.291 | 0.175 | 0.335 | 5 Hydroxytryptamine release inhibitor | 0.335 0.129 DBMET02688 0.296 0.169 DBMET02689 0.308 0.156 DBMET02690 0.314 0.15 DBMET02691 0.283 0.185 DBMET02693 0.242 0.239 DBMET02692 | DBMET02688 | |
| 0.118 | 0.005 | 0.118 | CC chemokine 5 receptor antagonist | 0.081 0.013 DBMET02688 0.074 0.016 DBMET02689 0.075 0.016 DBMET02690 0.084 0.012 DBMET02691 0.086 0.011 DBMET02693 0.058 0.028 DBMET02692 0.088 0.011 DBMET02694 | ||
| 0.13 | 0.018 | 0.13 | Dopamine D3 antagonist | 0.081 0.032 DBMET02689 0.103 0.024 DBMET02691 0.071 0.037 DBMET02693 0.103 0.024 DBMET02692 | ||
| 0.141 | 0.03 | 0.169 | Alpha 2 adrenoreceptor antagonist | 0.117 0.038 DBMET02688 0.077 0.07 DBMET02690 0.115 0.039 DBMET02691 0.169 0.023 DBMET02692 | DBMET02692 | |
| 0.116 | 0.005 | 0.172 | Potassium channel (Inward rectifier) blocker | 0.046 0.039 DBMET02689 0.172 0.004 DBMET02690 0.078 0.014 DBMET02691 0.097 0.008 DBMET02693 0.054 0.029 DBMET02692 0.046 0.039 DBMET02694 | DBMET02690 | |
| 0.16 | 0.049 | 0.233 | Toll-Like receptor antagonist | 0.233 0.02 DBMET02688 0.143 0.06 DBMET02691 0.166 0.045 DBMET02693 0.183 0.037 DBMET02692 | DBMET02688 | |
| 0.157 | 0.047 | 0.157 | Nav1.6 sodium channel blocker | 0.13 0.081 DBMET02688 0.115 0.104 DBMET02689 0.129 0.082 DBMET02691 | ||
| 0.146 | 0.037 | 0.156 | Sphingosine 1-phosphate receptor 4 antagonist | 0.156 0.028 DBMET02688 0.107 0.1 DBMET02689 0.132 0.053 DBMET02691 0.13 0.056 DBMET02693 0.114 0.084 DBMET02694 | DBMET02688 | |
| 0.114 | 0.005 | 0.137 | Sphingosine kinase 2 inhibitor | 0.063 0.028 DBMET02688 0.099 0.008 DBMET02689 0.057 0.036 DBMET02690 0.124 0.005 DBMET02691 0.137 0.004 DBMET02693 0.095 0.009 DBMET02692 0.058 0.034 DBMET02694 | DBMET02693 | |
| 0.121 | 0.013 | 0.121 | 5 Hydroxytryptamine 1A agonist | 0.044 0.034 DBMET02688 0.046 0.031 DBMET02689 0.065 0.024 DBMET02691 0.077 0.021 DBMET02693 0.049 0.029 DBMET02692 | ||
| 0.119 | 0.016 | 0.119 | Calcium channel L-type blocker | 0.079 0.041 DBMET02689 0.083 0.036 DBMET02691 0.097 0.026 DBMET02693 0.097 0.026 DBMET02692 0.076 0.043 DBMET02694 | ||
| 0.125 | 0.029 | 0.125 | 5 Hydroxytryptamine 1 antagonist | 0.08 0.047 DBMET02691 0.067 0.056 DBMET02693 0.077 0.049 DBMET02692 | ||
| 0.237 | 0.142 | 0.339 | Sodium/bile acid cotransporter inhibitor | 0.261 0.117 DBMET02688 0.291 0.088 DBMET02690 0.312 0.068 DBMET02691 0.229 0.151 DBMET02693 0.305 0.074 DBMET02692 0.339 0.047 DBMET02694 | DBMET02694 | |
| 0.129 | 0.033 | 0.163 | Prolactin inhibitor | 0.153 0.021 DBMET02688 0.082 0.078 DBMET02690 0.163 0.017 DBMET02691 0.115 0.042 DBMET02692 0.132 0.031 DBMET02694 | DBMET02691 | |
| 0.184 | 0.09 | 0.311 | DNA methylase inhibitor | 0.17 0.1 DBMET02688 0.158 0.111 DBMET02689 0.219 0.067 DBMET02691 0.195 0.082 DBMET02693 0.303 0.027 DBMET02692 0.311 0.025 DBMET02694 | DBMET02694 | |
| 0.125 | 0.031 | 0.14 | Dopamine antagonist | 0.075 0.05 DBMET02689 0.116 0.033 DBMET02691 0.083 0.046 DBMET02693 0.14 0.027 DBMET02692 | DBMET02692 | |
| 0.14 | 0.048 | 0.14 | 5 Hydroxytryptamine 2 antagonist | 0.091 0.079 DBMET02689 0.108 0.066 DBMET02693 | ||
| 0.115 | 0.024 | 0.115 | Histamine H2 receptor antagonist | 0.08 0.065 DBMET02688 0.088 0.051 DBMET02691 0.095 0.04 DBMET02693 | ||
| 0.167 | 0.076 | 0.168 | Antipruritic | 0.156 0.088 DBMET02691 0.151 0.093 DBMET02693 0.168 0.076 DBMET02694 | DBMET02694 | |
| 0.117 | 0.027 | 0.143 | CC chemokine receptor antagonist | 0.079 0.053 DBMET02688 0.143 0.019 DBMET02690 0.075 0.056 DBMET02691 0.081 0.05 DBMET02693 0.075 0.056 DBMET02694 | DBMET02690 | |
| 0.126 | 0.037 | 0.14 | Sphingomyelinase inhibitor | 0.086 0.077 DBMET02688 0.085 0.079 DBMET02689 0.122 0.04 DBMET02690 0.108 0.051 DBMET02691 0.114 0.046 DBMET02693 0.14 0.029 DBMET02692 | DBMET02692 | |
| 0.093 | 0.018 | 0.093 | Calcium channel T-type blocker | 0.053 0.049 DBMET02691 | ||
| 0.107 | 0.032 | 0.208 | Adrenaline agonist | 0.091 0.045 DBMET02688 0.154 0.014 DBMET02689 0.208 0.006 DBMET02690 0.168 0.011 DBMET02691 0.138 0.018 DBMET02693 0.137 0.019 DBMET02692 0.098 0.038 DBMET02694 | DBMET02690 | |
| 0.141 | 0.068 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.144 0.058 DBMET02688 0.161 0.023 DBMET02690 0.139 0.077 DBMET02691 0.131 0.114 DBMET02693 0.138 0.08 DBMET02694 | DBMET02690 | |
| 0.103 | 0.031 | 0.103 | 5 Hydroxytryptamine 1A antagonist | 0.071 0.045 DBMET02691 0.074 0.044 DBMET02692 | ||
| 0.222 | 0.151 | 0.343 | Antithrombotic | 0.224 0.149 DBMET02688 0.25 0.126 DBMET02689 0.275 0.107 DBMET02690 0.238 0.136 DBMET02691 0.229 0.144 DBMET02693 0.23 0.143 DBMET02692 0.343 0.067 DBMET02694 | DBMET02694 | |
| 0.095 | 0.026 | 0.095 | 5 Hydroxytryptamine 7 antagonist | 0.062 0.044 DBMET02691 0.055 0.049 DBMET02692 | ||
| 0.097 | 0.031 | 0.11 | Interferon agonist | 0.075 0.061 DBMET02688 0.096 0.032 DBMET02689 0.093 0.035 DBMET02690 0.084 0.046 DBMET02691 0.11 0.022 DBMET02693 0.088 0.04 DBMET02694 | DBMET02693 | |
| 0.073 | 0.009 | 0.08 | Substance P antagonist | 0.08 0.008 DBMET02688 0.042 0.024 DBMET02689 0.057 0.013 DBMET02690 0.044 0.022 DBMET02691 0.055 0.014 DBMET02693 0.038 0.029 DBMET02692 0.047 0.02 DBMET02694 | DBMET02688 | |
| 0.084 | 0.022 | 0.084 | Acetylcholine M5 receptor antagonist | 0.057 0.047 DBMET02688 0.073 0.028 DBMET02690 0.07 0.03 DBMET02691 0.075 0.027 DBMET02693 | ||
| 0.096 | 0.035 | 0.157 | 5 Hydroxytryptamine agonist | 0.157 0.02 DBMET02688 | DBMET02688 | |
| 0.085 | 0.024 | 0.169 | Adrenaline uptake inhibitor | 0.169 0.008 DBMET02688 0.065 0.039 DBMET02689 0.113 0.015 DBMET02690 0.065 0.039 DBMET02691 0.066 0.039 DBMET02693 | DBMET02688 | |
| 0.108 | 0.049 | 0.124 | Nitric-oxide synthase inhibitor | 0.124 0.035 DBMET02688 | DBMET02688 | |
| 0.066 | 0.007 | 0.066 | Sigma 2 receptor antagonist | 0.03 0.017 DBMET02689 0.048 0.01 DBMET02690 0.062 0.008 DBMET02691 0.038 0.013 DBMET02693 0.054 0.009 DBMET02692 0.023 0.022 DBMET02694 | ||
| 0.114 | 0.058 | 0.114 | Falcipain 3 inhibitor | 0.103 0.068 DBMET02688 0.099 0.072 DBMET02691 0.087 0.085 DBMET02693 0.088 0.083 DBMET02692 | ||
| 0.085 | 0.029 | 0.085 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.08 | 0.024 | 0.08 | 5 Hydroxytryptamine 5A antagonist | 0.056 0.054 DBMET02688 0.066 0.036 DBMET02691 0.061 0.043 DBMET02693 0.057 0.051 DBMET02692 | ||
| 0.117 | 0.061 | 0.124 | Alpha 2b adrenoreceptor antagonist | 0.094 0.08 DBMET02691 0.124 0.055 DBMET02692 | DBMET02692 | |
| 0.08 | 0.024 | 0.09 | Interferon inducer | 0.063 0.047 DBMET02688 0.065 0.043 DBMET02689 0.076 0.027 DBMET02690 0.068 0.037 DBMET02691 0.09 0.017 DBMET02693 0.066 0.042 DBMET02694 | DBMET02693 | |
| 0.073 | 0.019 | 0.073 | Neurokinin antagonist | 0.059 0.025 DBMET02688 0.046 0.04 DBMET02689 0.045 0.041 DBMET02690 0.056 0.028 DBMET02693 0.046 0.039 DBMET02694 | ||
| 0.073 | 0.018 | 0.073 | Histamine H3 receptor antagonist | |||
| 0.09 | 0.037 | 0.09 | Acetylcholine M4 receptor antagonist | 0.084 0.042 DBMET02688 0.066 0.062 DBMET02693 | ||
| 0.123 | 0.071 | 0.135 | Cathepsin H inhibitor | 0.128 0.066 DBMET02688 0.135 0.059 DBMET02689 | DBMET02689 | |
| 0.088 | 0.036 | 0.104 | Dopamine D2 antagonist | 0.082 0.039 DBMET02691 0.055 0.053 DBMET02693 0.104 0.031 DBMET02692 | DBMET02692 | |
| 0.099 | 0.047 | 0.099 | 5 Hydroxytryptamine 2A antagonist | 0.076 0.062 DBMET02693 | ||
| 0.059 | 0.009 | 0.059 | Sigma 1 receptor antagonist | 0.038 0.013 DBMET02690 0.037 0.014 DBMET02691 0.032 0.016 DBMET02693 0.028 0.018 DBMET02692 | ||
| 0.125 | 0.084 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.124 0.087 DBMET02688 0.121 0.093 DBMET02691 | ||
| 0.211 | 0.171 | 0.309 | Interleukin 2 agonist | 0.247 0.122 DBMET02688 0.229 0.144 DBMET02689 0.277 0.092 DBMET02690 0.248 0.12 DBMET02691 0.261 0.107 DBMET02693 0.201 0.188 DBMET02692 0.309 0.068 DBMET02694 | DBMET02694 | |
| 0.171 | 0.133 | 0.178 | 5 Hydroxytryptamine 3E antagonist | 0.178 0.112 DBMET02688 | DBMET02688 | |
| 0.065 | 0.03 | 0.065 | 5 Hydroxytryptamine 5 antagonist | 0.054 0.047 DBMET02691 | ||
| 0.136 | 0.1 | 0.302 | Growth hormone agonist | 0.121 0.12 DBMET02688 0.148 0.089 DBMET02689 0.161 0.079 DBMET02691 0.136 0.1 DBMET02693 0.302 0.032 DBMET02694 | DBMET02694 | |
| 0.199 | 0.165 | 0.339 | Immunomodulator | 0.259 0.108 DBMET02688 0.339 0.064 DBMET02689 0.247 0.117 DBMET02693 0.226 0.136 DBMET02694 | DBMET02689 | |
| 0.059 | 0.025 | 0.059 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.039 DBMET02688 | ||
| 0.054 | 0.021 | 0.063 | Opioid kappa receptor agonist | 0.038 0.037 DBMET02689 0.039 0.036 DBMET02690 0.063 0.017 DBMET02691 0.043 0.03 DBMET02693 0.043 0.03 DBMET02692 0.05 0.024 DBMET02694 | DBMET02691 | |
| 0.12 | 0.088 | 0.177 | Vanilloid 1 agonist | 0.117 0.094 DBMET02688 0.134 0.058 DBMET02691 0.126 0.074 DBMET02693 0.177 0.019 DBMET02692 0.125 0.076 DBMET02694 | DBMET02692 | |
| 0.057 | 0.026 | 0.067 | Bombesin 2 receptor antagonist | 0.06 0.024 DBMET02689 0.054 0.029 DBMET02691 0.054 0.029 DBMET02693 0.046 0.039 DBMET02692 0.067 0.021 DBMET02694 | DBMET02694 | |
| 0.106 | 0.076 | 0.106 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.061 | 0.03 | 0.065 | 5 Hydroxytryptamine 7 agonist | 0.065 0.025 DBMET02688 0.057 0.037 DBMET02691 0.06 0.031 DBMET02692 | DBMET02688 | |
| 0.064 | 0.033 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.042 DBMET02688 0.063 0.034 DBMET02691 0.06 0.038 DBMET02693 | ||
| 0.074 | 0.044 | 0.087 | Phospholipase D inhibitor | 0.087 0.025 DBMET02688 0.068 0.058 DBMET02690 0.078 0.038 DBMET02694 | DBMET02688 | |
| 0.107 | 0.078 | 0.234 | Cell adhesion inhibitor | 0.1 0.09 DBMET02691 0.118 0.067 DBMET02693 0.102 0.085 DBMET02692 0.234 0.017 DBMET02694 | DBMET02694 | |
| 0.118 | 0.088 | 0.19 | Toll-Like receptor 9 antagonist | 0.19 0.04 DBMET02688 | DBMET02688 | |
| 0.113 | 0.085 | 0.207 | Alpha-N-acetylglucosaminidase inhibitor | 0.207 0.032 DBMET02688 0.205 0.033 DBMET02689 0.146 0.057 DBMET02690 0.17 0.045 DBMET02693 0.188 0.038 DBMET02694 | DBMET02688 | |
| 0.079 | 0.051 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 DBMET02688 | DBMET02688 | |
| 0.048 | 0.02 | 0.054 | Neurokinin 1 antagonist | 0.054 0.017 DBMET02688 0.041 0.028 DBMET02690 0.04 0.029 DBMET02693 | DBMET02688 | |
| 0.064 | 0.036 | 0.078 | Beta 2 adrenoreceptor agonist | 0.063 0.037 DBMET02689 0.078 0.01 DBMET02690 0.076 0.012 DBMET02691 0.071 0.017 DBMET02693 0.069 0.021 DBMET02692 0.06 0.052 DBMET02694 | DBMET02690 | |
| 0.073 | 0.045 | 0.103 | CXC chemokine receptor antagonist | 0.103 0.023 DBMET02688 0.064 0.059 DBMET02691 | DBMET02688 | |
| 0.047 | 0.021 | 0.098 | Leukotriene A4 hydrolase inhibitor | 0.039 0.025 DBMET02691 0.067 0.013 DBMET02693 0.098 0.006 DBMET02694 | DBMET02694 | |
| 0.089 | 0.063 | 0.169 | Antiadrenergic | 0.156 0.034 DBMET02689 0.169 0.031 DBMET02690 0.083 0.068 DBMET02691 0.093 0.06 DBMET02693 0.103 0.054 DBMET02692 | DBMET02690 | |
| 0.056 | 0.031 | 0.059 | Histamine agonist | 0.059 0.028 DBMET02688 | DBMET02688 | |
| 0.087 | 0.063 | 0.166 | Adrenaline antagonist | 0.153 0.034 DBMET02689 0.166 0.031 DBMET02690 0.081 0.067 DBMET02691 0.091 0.06 DBMET02693 0.1 0.054 DBMET02692 | DBMET02690 | |
| 0.037 | 0.013 | 0.065 | Epoxide hydrolase 1 inhibitor | 0.065 0.004 DBMET02688 0.031 0.021 DBMET02694 | DBMET02688 | |
| 0.098 | 0.074 | 0.12 | Toll-Like receptor 4 antagonist | 0.113 0.051 DBMET02689 0.119 0.045 DBMET02691 0.1 0.07 DBMET02693 0.12 0.043 DBMET02692 0.117 0.047 DBMET02694 | DBMET02692 | |
| 0.047 | 0.024 | 0.072 | Beta adrenoreceptor agonist | 0.043 0.042 DBMET02688 0.058 0.009 DBMET02689 0.072 0.005 DBMET02690 0.061 0.008 DBMET02691 0.054 0.012 DBMET02693 0.051 0.015 DBMET02692 0.047 0.026 DBMET02694 | DBMET02690 | |
| 0.128 | 0.105 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.107 DBMET02688 0.122 0.119 DBMET02691 | ||
| 0.057 | 0.035 | 0.069 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.041 DBMET02688 0.059 0.031 DBMET02690 0.057 0.036 DBMET02691 0.056 0.038 DBMET02693 0.069 0.019 DBMET02694 | DBMET02694 | |
| 0.076 | 0.055 | 0.083 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.059 DBMET02688 0.077 0.052 DBMET02690 0.076 0.055 DBMET02691 0.083 0.04 DBMET02694 | DBMET02694 | |
| 0.04 | 0.021 | 0.04 | Delayed rectifier potassium channel blocker | 0.034 0.033 DBMET02691 | ||
| 0.095 | 0.076 | 0.167 | Ferrochelatase inhibitor | 0.16 0.034 DBMET02688 0.147 0.039 DBMET02690 0.167 0.031 DBMET02694 | DBMET02694 | |
| 0.031 | 0.013 | 0.031 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.031 0.013 DBMET02691 0.026 0.021 DBMET02693 0.028 0.017 DBMET02694 | ||
| 0.107 | 0.088 | 0.118 | Transcription factor STAT6 inhibitor | 0.106 0.09 DBMET02688 0.118 0.063 DBMET02690 0.114 0.071 DBMET02691 | DBMET02690 | |
| 0.023 | 0.005 | 0.023 | CXC chemokine 5 receptor antagonist | 0.017 0.013 DBMET02689 0.018 0.012 DBMET02690 0.017 0.013 DBMET02693 0.021 0.007 DBMET02694 | ||
| 0.024 | 0.006 | 0.029 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.029 0.004 DBMET02688 0.021 0.013 DBMET02689 0.024 0.005 DBMET02690 0.02 0.016 DBMET02691 0.021 0.011 DBMET02693 | DBMET02688 | |
| 0.049 | 0.031 | 0.052 | Potassium channel Kv1.3 blocker | 0.049 0.03 DBMET02691 0.048 0.032 DBMET02693 0.052 0.028 DBMET02692 | DBMET02692 | |
| 0.125 | 0.107 | 0.14 | Thiol protease inhibitor | 0.14 0.08 DBMET02688 0.125 0.106 DBMET02693 | DBMET02688 | |
| 0.053 | 0.036 | 0.053 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.085 | 0.068 | 0.108 | Alpha adrenoreceptor antagonist | 0.083 0.069 DBMET02689 0.082 0.07 DBMET02690 0.108 0.052 DBMET02692 | DBMET02692 | |
| 0.073 | 0.057 | 0.134 | GABA aminotransferase inhibitor | 0.09 0.035 DBMET02691 0.134 0.011 DBMET02694 | DBMET02694 | |
| 0.059 | 0.043 | 0.059 | Dopamine D4 antagonist | |||
| 0.056 | 0.04 | 0.056 | Potassium channel Kv1.5 blocker | |||
| 0.057 | 0.042 | 0.06 | Cathepsin L inhibitor | 0.06 0.039 DBMET02688 | DBMET02688 | |
| 0.037 | 0.023 | 0.037 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.079 | 0.065 | 0.108 | Calcium antagonist | 0.108 0.042 DBMET02690 | DBMET02690 | |
| 0.052 | 0.038 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | 0.061 0.025 DBMET02688 0.05 0.044 DBMET02693 | DBMET02688 | |
| 0.069 | 0.055 | 0.071 | Epoxide hydrolase inhibitor | 0.071 0.052 DBMET02688 | DBMET02688 | |
| 0.042 | 0.028 | 0.042 | Histone deacetylase 8 inhibitor | |||
| 0.079 | 0.066 | 0.099 | Ca(v)2.2 blocker | 0.099 0.049 DBMET02688 | DBMET02688 | |
| 0.046 | 0.033 | 0.078 | Glycine transporter 2 inhibitor | 0.045 0.034 DBMET02688 0.078 0.018 DBMET02690 0.068 0.022 DBMET02691 0.04 0.038 DBMET02692 0.06 0.025 DBMET02694 | DBMET02690 | |
| 0.031 | 0.019 | 0.031 | 5 Hydroxytryptamine 1D agonist | |||
| 0.085 | 0.074 | 0.096 | Glutamate release inhibitor | 0.096 0.049 DBMET02694 | DBMET02694 | |
| 0.036 | 0.024 | 0.056 | Ceramide glucosyltransferase inhibitor | 0.036 0.025 DBMET02688 0.056 0.005 DBMET02690 0.035 0.026 DBMET02691 0.044 0.012 DBMET02693 | DBMET02690 | |
| 0.032 | 0.02 | 0.032 | Peptide deformylase inhibitor | 0.031 0.02 DBMET02688 | ||
| 0.023 | 0.011 | 0.023 | Apolipoprotein B inhibitor | |||
| 0.031 | 0.019 | 0.062 | Potassium channel (Inward rectifier) 1 blocker | 0.062 0.003 DBMET02690 0.031 0.019 DBMET02693 | DBMET02690 | |
| 0.032 | 0.021 | 0.032 | CXC chemokine 3 receptor antagonist | |||
| 0.205 | 0.195 | 0.314 | Toll-Like receptor agonist | 0.314 0.102 DBMET02690 0.269 0.132 DBMET02693 0.303 0.109 DBMET02694 | DBMET02690 | |
| 0.089 | 0.08 | 0.24 | GABA C receptor rho-1 antagonist | 0.24 0.005 DBMET02688 | DBMET02688 | |
| 0.025 | 0.018 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 DBMET02688 | DBMET02688 | |
| 0.05 | 0.044 | 0.052 | CC chemokine 2 receptor antagonist | 0.052 0.042 DBMET02690 | DBMET02690 | |
| 0.086 | 0.081 | 0.086 | Alpha 2d adrenoreceptor antagonist | |||
| 0.041 | 0.036 | 0.051 | Histamine H1 receptor agonist | 0.051 0.017 DBMET02688 | DBMET02688 | |
| 0.035 | 0.03 | 0.035 | Melanocortin 1 antagonist | |||
| 0.035 | 0.033 | 0.036 | Dopamine D3 agonist | 0.036 0.032 DBMET02691 | DBMET02691 | |
| 0.082 | 0.08 | 0.131 | Aminopeptidase B inhibitor | 0.084 0.078 DBMET02688 0.086 0.076 DBMET02689 0.103 0.063 DBMET02693 0.131 0.046 DBMET02694 | DBMET02694 | |
| 0.022 | 0.021 | 0.022 | CC chemokine 8 receptor antagonist | |||
| 0.095 | 0.094 | 0.133 | Cholesterol synthesis inhibitor | 0.109 0.076 DBMET02689 0.129 0.058 DBMET02690 0.12 0.065 DBMET02691 0.102 0.085 DBMET02693 0.133 0.054 DBMET02692 0.129 0.057 DBMET02694 | DBMET02692 | |
| 0.012 | 0.012 | 0.013 | Melatonin receptor 1A antagonist | 0.013 0.011 DBMET02688 | DBMET02688 | |
| 0.018 | 0.022 | 0.086 | Prostaglandin D2 antagonist | 0.022 0.017 DBMET02693 0.086 0.005 DBMET02694 | DBMET02694 | |
| 0.162 | 0.167 | 0.267 | Superoxide dismutase inhibitor | 0.237 0.083 DBMET02688 0.2 0.117 DBMET02691 0.181 0.14 DBMET02693 0.267 0.065 DBMET02692 | DBMET02692 | |
| 0.067 | 0.073 | 0.085 | Vanilloid 4 agonist | 0.085 0.033 DBMET02688 | DBMET02688 | |
| 0.039 | 0.046 | 0.064 | Dopamine transporter inhibitor | 0.064 0.023 DBMET02688 0.046 0.036 DBMET02690 | DBMET02688 | |
| 0.053 | 0.061 | 0.067 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.067 0.031 DBMET02691 0.062 0.038 DBMET02692 | DBMET02691 | |
| 0.048 | 0.056 | 0.058 | Epithelial sodium channel blocker | 0.058 0.031 DBMET02688 0.05 0.048 DBMET02693 | DBMET02688 | |
| 0.033 | 0.041 | 0.062 | Dopamine D5 agonist | 0.062 0.011 DBMET02688 0.057 0.013 DBMET02691 0.039 0.028 DBMET02692 | DBMET02688 | |
| 0.05 | 0.059 | 0.088 | 5 Hydroxytryptamine 2A agonist | 0.088 0.021 DBMET02688 | DBMET02688 | |
| 0.035 | 0.044 | 0.043 | Plasmepsin II inhibitor | 0.043 0.025 DBMET02688 | DBMET02688 | |
| 0.031 | 0.04 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.036 0.028 DBMET02693 | DBMET02693 | |
| 0.052 | 0.062 | 0.085 | Dopamine D1 antagonist | 0.077 0.034 DBMET02691 0.085 0.03 DBMET02692 | DBMET02692 | |
| 0.035 | 0.046 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET02689 0.055 0.025 DBMET02693 | DBMET02689 | |
| 0.088 | 0.099 | 0.264 | GABA C receptor antagonist | 0.264 0.005 DBMET02688 | DBMET02688 | |
| 0.032 | 0.044 | 0.063 | GABA uptake inhibitor | 0.063 0.009 DBMET02693 0.058 0.011 DBMET02694 | DBMET02693 | |
| 0.029 | 0.042 | 0.037 | Cathepsin L1 inhibitor | 0.037 0.03 DBMET02688 | DBMET02688 | |
| 0.056 | 0.069 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.065 0.042 DBMET02688 0.063 0.047 DBMET02689 0.093 0.017 DBMET02690 0.073 0.03 DBMET02691 0.063 0.049 DBMET02693 0.072 0.031 DBMET02692 | DBMET02690 | |
| 0.02 | 0.034 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.022 DBMET02688 | DBMET02688 | |
| 0.114 | 0.128 | 0.138 | Hexokinase inhibitor | 0.126 0.109 DBMET02689 0.138 0.093 DBMET02691 0.128 0.107 DBMET02693 0.136 0.096 DBMET02694 | DBMET02691 | |
| 0.096 | 0.111 | 0.189 | Toll-Like receptor 2 antagonist | 0.166 0.042 DBMET02688 0.146 0.056 DBMET02691 0.189 0.029 DBMET02692 0.122 0.075 DBMET02694 | DBMET02692 | |
| 0.194 | 0.209 | 0.301 | Toll-Like receptor 7 agonist | 0.301 0.109 DBMET02690 0.266 0.134 DBMET02693 0.296 0.112 DBMET02694 | DBMET02690 | |
| 0.058 | 0.073 | 0.099 | Aminopeptidase I inhibitor | 0.087 0.036 DBMET02689 0.072 0.051 DBMET02693 0.099 0.029 DBMET02694 | DBMET02694 | |
| 0.084 | 0.1 | 0.111 | Glutamate (mGluR7) agonist | 0.091 0.081 DBMET02688 0.093 0.075 DBMET02690 0.111 0.041 DBMET02694 | DBMET02694 | |
| 0.017 | 0.033 | 0.028 | Motilin receptor agonist | 0.028 0.01 DBMET02688 | DBMET02688 | |
| 0.03 | 0.046 | 0.046 | Dopamine D2 agonist | 0.046 0.029 DBMET02691 0.044 0.031 DBMET02692 | DBMET02691 | |
| 0.222 | 0.239 | 0.485 | Calcium channel L-type activator | 0.301 0.157 DBMET02688 0.266 0.188 DBMET02689 0.485 0.034 DBMET02690 0.355 0.113 DBMET02691 0.275 0.18 DBMET02693 0.266 0.188 DBMET02692 0.262 0.193 DBMET02694 | DBMET02690 | |
| 0.133 | 0.15 | 0.159 | Neurotensin receptor agonist | 0.155 0.091 DBMET02688 0.157 0.086 DBMET02691 0.138 0.135 DBMET02692 0.159 0.08 DBMET02694 | DBMET02694 | |
| 0.044 | 0.061 | 0.057 | Fibroblast growth factor 4 antagonist | 0.057 0.042 DBMET02688 0.052 0.049 DBMET02693 | DBMET02688 | |
| 0.09 | 0.108 | 0.135 | Electron transport complex I inhibitor | 0.135 0.031 DBMET02690 0.132 0.033 DBMET02692 | DBMET02690 | |
| 0.122 | 0.141 | 0.259 | DNA methyltransferase I inhibitor | 0.177 0.082 DBMET02688 0.149 0.105 DBMET02691 0.259 0.043 DBMET02692 0.25 0.047 DBMET02694 | DBMET02692 | |
| 0.076 | 0.095 | 0.137 | Creatine kinase inhibitor | 0.085 0.078 DBMET02688 0.137 0.03 DBMET02691 | DBMET02691 | |
| 0.033 | 0.052 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.033 DBMET02688 | DBMET02688 | |
| 0.017 | 0.037 | 0.027 | Melatonin antagonist | 0.027 0.022 DBMET02688 | DBMET02688 | |
| 0.079 | 0.099 | 0.126 | Toll-Like receptor 3 antagonist | 0.126 0.025 DBMET02690 | DBMET02690 | |
| 0.029 | 0.049 | 0.04 | Oxytocin agonist | 0.039 0.033 DBMET02688 0.04 0.032 DBMET02691 | DBMET02691 | |
| 0.013 | 0.033 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET02688 0.019 0.014 DBMET02694 | DBMET02694 | |
| 0.022 | 0.043 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.04 0.016 DBMET02691 0.029 0.027 DBMET02692 | DBMET02691 | |
| 0.057 | 0.081 | 0.069 | Alpha 2a adrenoreceptor antagonist | 0.069 0.059 DBMET02692 | DBMET02692 | |
| 0.119 | 0.143 | 0.164 | Amyloid beta precursor protein antagonist | 0.147 0.105 DBMET02691 0.153 0.099 DBMET02693 0.164 0.087 DBMET02692 0.13 0.127 DBMET02694 | DBMET02692 | |
| 0.03 | 0.054 | 0.036 | AMPA 4 receptor antagonist | 0.036 0.034 DBMET02694 | DBMET02694 | |
| 0.053 | 0.079 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 DBMET02688 | DBMET02688 | |
| 0.192 | 0.219 | 0.355 | GABA C receptor rho-3 antagonist | 0.355 0.083 DBMET02688 0.219 0.185 DBMET02691 | DBMET02688 | |
| 0.113 | 0.14 | 0.151 | Death-associated protein kinase 1 inhibitor | 0.151 0.038 DBMET02688 | DBMET02688 | |
| 0.168 | 0.198 | 0.268 | Cholesterol antagonist | 0.188 0.176 DBMET02690 0.224 0.144 DBMET02691 0.207 0.159 DBMET02692 0.268 0.113 DBMET02694 | DBMET02694 | |
| 0.08 | 0.112 | 0.132 | DNA polymerase I inhibitor | 0.115 0.072 DBMET02691 0.132 0.06 DBMET02692 0.099 0.087 DBMET02694 | DBMET02692 | |
| 0.024 | 0.056 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 DBMET02694 | DBMET02694 | |
| 0.052 | 0.085 | 0.07 | Cathepsin G inhibitor | 0.07 0.054 DBMET02694 | DBMET02694 | |
| 0.049 | 0.082 | 0.062 | Protease 3C (Human rhinovirus) inhibitor | 0.062 0.048 DBMET02688 | DBMET02688 | |
| 0.041 | 0.075 | 0.068 | Vanilloid 2 antagonist | 0.049 0.045 DBMET02691 0.068 0.015 DBMET02692 | DBMET02692 | |
| 0.018 | 0.053 | 0.032 | Kainate receptor 2 antagonist | 0.032 0.028 DBMET02694 | DBMET02694 | |
| 0.061 | 0.097 | 0.143 | Cell adhesion molecule inhibitor | 0.143 0.017 DBMET02694 | DBMET02694 | |
| 0.039 | 0.077 | 0.069 | Selectin antagonist | 0.069 0.043 DBMET02694 | DBMET02694 | |
| 0.017 | 0.056 | 0.048 | Cholecystokinin antagonist | 0.048 0.026 DBMET02694 | DBMET02694 | |
| 0.038 | 0.077 | 0.063 | Alpha 1 adrenoreceptor agonist | 0.063 0.034 DBMET02690 | DBMET02690 | |
| 0.04 | 0.08 | 0.07 | Dopamine agonist | 0.057 0.055 DBMET02691 0.07 0.044 DBMET02692 | DBMET02692 | |
| 0.125 | 0.167 | 0.164 | Succinate dehydrogenase inhibitor | 0.164 0.089 DBMET02688 0.149 0.115 DBMET02693 0.147 0.119 DBMET02692 0.164 0.089 DBMET02694 | DBMET02694 | |
| 0.062 | 0.103 | 0.117 | Inducible nitric-oxide synthase inhibitor | 0.117 0.026 DBMET02688 | DBMET02688 | |
| 0.026 | 0.068 | 0.065 | NMDA 2A receptor antagonist | 0.065 0.027 DBMET02690 0.049 0.039 DBMET02691 0.048 0.04 DBMET02694 | DBMET02690 | |
| 0.029 | 0.072 | 0.161 | Prostaglandin antagonist | 0.161 0.009 DBMET02694 | DBMET02694 | |
| 0.003 | 0.047 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET02694 | DBMET02694 | |
| 0.046 | 0.09 | 0.056 | Leukotriene C antagonist | 0.056 0.039 DBMET02694 | DBMET02694 | |
| 0.004 | 0.049 | 0.013 | Prostaglandin EP4 agonist | 0.013 0.011 DBMET02694 | DBMET02694 | |
| 0.012 | 0.059 | 0.048 | Sphingosine 1-phosphate receptor 3 agonist | 0.048 0.017 DBMET02690 0.033 0.025 DBMET02693 | DBMET02690 | |
| 0.018 | 0.065 | 0.025 | Myristoyl transferase inhibitor | 0.025 0.024 DBMET02688 | DBMET02688 | |
| 0.04 | 0.087 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.018 DBMET02688 0.056 0.036 DBMET02690 0.054 0.04 DBMET02693 | DBMET02688 | |
| 0.025 | 0.075 | 0.041 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.033 DBMET02689 0.041 0.031 DBMET02694 | DBMET02694 | |
| 0.036 | 0.087 | 0.087 | NMDA 2C receptor antagonist | 0.087 0.021 DBMET02690 0.071 0.032 DBMET02694 | DBMET02690 | |
| 0.057 | 0.108 | 0.102 | Glycine receptor antagonist | 0.102 0.03 DBMET02688 | DBMET02688 | |
| 0.035 | 0.087 | 0.057 | Alpha-mannosidase inhibitor | 0.054 0.035 DBMET02688 0.057 0.031 DBMET02690 0.049 0.045 DBMET02693 | DBMET02690 | |
| 0.016 | 0.069 | 0.033 | 5-Alpha-reductase inhibitor | 0.033 0.031 DBMET02694 | DBMET02694 | |
| 0.052 | 0.108 | 0.095 | Acetylcholine nicotinic agonist | 0.095 0.041 DBMET02688 | DBMET02688 | |
| 0.011 | 0.067 | 0.044 | Arginase inhibitor | 0.044 0.019 DBMET02694 | DBMET02694 | |
| 0.066 | 0.125 | 0.269 | GABA C receptor agonist | 0.25 0.013 DBMET02688 0.269 0.012 DBMET02694 | DBMET02694 | |
| 0.029 | 0.089 | 0.045 | Integrin alpha1beta1 antagonist | 0.045 0.012 DBMET02694 | DBMET02694 | |
| 0.158 | 0.219 | 0.186 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.186 0.174 DBMET02692 | DBMET02692 | |
| 0.017 | 0.079 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.024 DBMET02688 | DBMET02688 | |
| 0.006 | 0.069 | 0.014 | Prostacyclin agonist | 0.014 0.012 DBMET02694 | DBMET02694 | |
| 0.068 | 0.131 | 0.111 | 5 Hydroxytryptamine 3A agonist | 0.111 0.064 DBMET02688 | DBMET02688 | |
| 0.043 | 0.107 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | 0.072 0.026 DBMET02688 | DBMET02688 | |
| 0.036 | 0.101 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.048 DBMET02688 | DBMET02688 | |
| 0.013 | 0.077 | 0.029 | Prostaglandin agonist | 0.029 0.024 DBMET02694 | DBMET02694 | |
| 0.035 | 0.1 | 0.063 | Carbonic anhydrase stimulant | 0.063 0.038 DBMET02688 | DBMET02688 | |
| 0.035 | 0.1 | 0.116 | NMDA 2 receptor antagonist | 0.116 0.025 DBMET02690 0.073 0.049 DBMET02691 | DBMET02690 | |
| 0.04 | 0.106 | 0.08 | Cathepsin E inhibitor | 0.08 0.022 DBMET02689 | DBMET02689 | |
| 0.049 | 0.115 | 0.072 | Acetylcholine nicotinic antagonist | 0.072 0.065 DBMET02688 | DBMET02688 | |
| 0.014 | 0.082 | 0.051 | Plasmepsin I inhibitor | 0.051 0.007 DBMET02689 | DBMET02689 | |
| 0.065 | 0.138 | 0.104 | Vanilloid agonist | 0.104 0.029 DBMET02692 | DBMET02692 | |
| 0.061 | 0.134 | 0.144 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.089 0.066 DBMET02689 0.144 0.029 DBMET02694 | DBMET02694 | |
| 0.066 | 0.14 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | 0.119 0.036 DBMET02694 | DBMET02694 | |
| 0.015 | 0.089 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 DBMET02690 | DBMET02690 | |
| 0.101 | 0.176 | 0.147 | Adenylate cyclase stimulant | 0.147 0.068 DBMET02688 0.133 0.094 DBMET02690 0.13 0.102 DBMET02694 | DBMET02688 | |
| 0.013 | 0.088 | 0.033 | Prostaglandin D2 agonist | 0.029 0.024 DBMET02689 0.033 0.019 DBMET02690 0.033 0.018 DBMET02694 | DBMET02694 | |
| 0.023 | 0.098 | 0.046 | Mannosidase inhibitor | 0.046 0.03 DBMET02688 0.043 0.034 DBMET02690 | DBMET02688 | |
| 0.026 | 0.102 | 0.052 | Beta 2 adrenoreceptor antagonist | 0.052 0.034 DBMET02690 | DBMET02690 | |
| 0.032 | 0.108 | 0.097 | Cyclin A2 inhibitor | 0.097 0.026 DBMET02688 | DBMET02688 | |
| 0.052 | 0.127 | 0.093 | Acetylcholine agonist | 0.093 0.052 DBMET02688 | DBMET02688 | |
| 0.012 | 0.088 | 0.06 | GP IIb/IIIa receptor antagonist | 0.06 0.028 DBMET02694 | DBMET02694 | |
| 0.021 | 0.099 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.034 DBMET02688 | DBMET02688 | |
| 0.024 | 0.102 | 0.039 | Glutamate (mGluR8) antagonist | 0.039 0.018 DBMET02694 | DBMET02694 | |
| 0.119 | 0.198 | 0.133 | Heat shock protein 70 antagonist | 0.13 0.122 DBMET02688 0.133 0.107 DBMET02694 | DBMET02694 | |
| 0.007 | 0.087 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 DBMET02688 | DBMET02688 | |
| 0.036 | 0.116 | 0.063 | Alpha adrenoreceptor agonist | 0.063 0.052 DBMET02690 | DBMET02690 | |
| 0.156 | 0.239 | 0.261 | Insulysin inhibitor | 0.214 0.137 DBMET02688 0.261 0.086 DBMET02694 | DBMET02694 | |
| 0.086 | 0.169 | 0.167 | Anticoagulant | 0.121 0.11 DBMET02688 0.167 0.067 DBMET02694 | DBMET02694 | |
| 0.11 | 0.195 | 0.241 | Platelet aggregation inhibitor | 0.146 0.133 DBMET02692 0.241 0.056 DBMET02694 | DBMET02694 | |
| 0.029 | 0.115 | 0.087 | Cyclin A inhibitor | 0.087 0.028 DBMET02688 | DBMET02688 | |
| 0.095 | 0.184 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.09 DBMET02691 0.112 0.106 DBMET02692 | DBMET02691 | |
| 0.151 | 0.24 | 0.502 | Vasodilator, peripheral | 0.239 0.136 DBMET02688 0.502 0.027 DBMET02690 0.21 0.165 DBMET02692 0.21 0.165 DBMET02694 | DBMET02690 | |
| 0.025 | 0.116 | 0.054 | Nicotinic neuronal receptor agonist | 0.054 0.042 DBMET02688 | DBMET02688 | |
| 0.063 | 0.155 | 0.083 | Estrogen-related receptor beta agonist | 0.082 0.061 DBMET02691 0.083 0.058 DBMET02693 | DBMET02693 | |
| 0.035 | 0.127 | 0.064 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.041 DBMET02690 0.064 0.021 DBMET02694 | DBMET02694 | |
| 0.045 | 0.14 | 0.116 | NMDA receptor antagonist | 0.116 0.037 DBMET02690 0.082 0.062 DBMET02694 | DBMET02690 | |
| 0.006 | 0.101 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.013 DBMET02688 | DBMET02688 | |
| 0.047 | 0.142 | 0.072 | Glycine receptor agonist | 0.072 0.051 DBMET02688 | DBMET02688 | |
| 0.035 | 0.135 | 0.087 | Beta adrenoreceptor antagonist | 0.06 0.056 DBMET02689 0.087 0.022 DBMET02690 0.062 0.052 DBMET02692 | DBMET02690 | |
| 0.112 | 0.212 | 0.169 | Phospholipase C inhibitor | 0.169 0.073 DBMET02688 | DBMET02688 | |
| 0.008 | 0.111 | 0.049 | Renin inhibitor | 0.049 0.018 DBMET02689 | DBMET02689 | |
| 0.106 | 0.209 | 0.179 | Immunostimulant | 0.153 0.152 DBMET02688 0.179 0.133 DBMET02689 0.17 0.139 DBMET02690 0.159 0.147 DBMET02694 | DBMET02689 | |
| 0.051 | 0.156 | 0.065 | MDM2 inhibitor | 0.065 0.055 DBMET02694 | DBMET02694 | |
| 0.02 | 0.129 | 0.042 | Somatostatin 4 agonist | 0.042 0.02 DBMET02688 | DBMET02688 | |
| 0.028 | 0.14 | 0.06 | Alpha 2 adrenoreceptor agonist | 0.06 0.043 DBMET02688 | DBMET02688 | |
| 0.025 | 0.142 | 0.059 | Biliverdin reductase inhibitor | 0.059 0.042 DBMET02694 | DBMET02694 | |
| 0.04 | 0.158 | 0.097 | Glutamate dehydrogenase inhibitor | 0.097 0.032 DBMET02694 | DBMET02694 | |
| 0.06 | 0.18 | 0.105 | Mucolytic | 0.097 0.082 DBMET02692 0.105 0.071 DBMET02694 | DBMET02694 | |
| 0.023 | 0.143 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 DBMET02690 | DBMET02690 | |
| 0.05 | 0.17 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.059 DBMET02691 | DBMET02691 | |
| 0.033 | 0.154 | 0.103 | Glutamate decarboxylase inhibitor | 0.103 0.028 DBMET02694 | DBMET02694 | |
| 0.008 | 0.129 | 0.033 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET02688 | DBMET02688 | |
| 0.154 | 0.276 | 0.231 | Histamine release inhibitor | 0.231 0.171 DBMET02690 0.202 0.199 DBMET02694 | DBMET02690 | |
| 0.131 | 0.253 | 0.197 | RNA-directed DNA polymerase inhibitor | 0.197 0.104 DBMET02688 | DBMET02688 | |
| 0.029 | 0.151 | 0.063 | Catalase inhibitor | 0.063 0.061 DBMET02694 | DBMET02694 | |
| 0.059 | 0.189 | 0.086 | Hematopoietic | 0.086 0.058 DBMET02694 | DBMET02694 | |
| 0.01 | 0.142 | 0.031 | Fumarate hydratase inhibitor | 0.031 0.027 DBMET02694 | DBMET02694 | |
| 0.023 | 0.156 | 0.078 | Carbamoyl phosphate synthetase inhibitor | 0.078 0.03 DBMET02694 | DBMET02694 | |
| 0.02 | 0.153 | 0.049 | Toll-Like receptor 8 antagonist | 0.049 0.043 DBMET02688 | DBMET02688 | |
| 0.118 | 0.255 | 0.154 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.154 0.139 DBMET02692 | DBMET02692 | |
| 0.015 | 0.157 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 DBMET02694 | DBMET02694 | |
| 0.052 | 0.195 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.041 DBMET02688 0.075 0.061 DBMET02693 | DBMET02688 | |
| 0.047 | 0.191 | 0.108 | Breast cancer-resistant protein inhibitor | 0.108 0.048 DBMET02692 | DBMET02692 | |
| 0.134 | 0.28 | 0.232 | Immunosuppressant | 0.232 0.164 DBMET02689 0.212 0.184 DBMET02693 0.202 0.195 DBMET02694 | DBMET02689 | |
| 0.048 | 0.197 | 0.081 | GABA B receptor agonist | 0.081 0.04 DBMET02694 | DBMET02694 | |
| 0.042 | 0.191 | 0.096 | Protease inhibitor | 0.096 0.069 DBMET02689 | DBMET02689 | |
| 0.14 | 0.29 | 0.335 | Antiobesity | 0.208 0.199 DBMET02688 0.335 0.095 DBMET02690 | DBMET02690 | |
| 0.086 | 0.236 | 0.143 | Melanin inhibitor | 0.143 0.092 DBMET02692 | DBMET02692 | |
| 0.048 | 0.2 | 0.107 | Triose-phosphate isomerase inhibitor | 0.107 0.042 DBMET02694 | DBMET02694 | |
| 0.09 | 0.243 | 0.341 | Platelet antagonist | 0.341 0.04 DBMET02694 | DBMET02694 | |
| 0.086 | 0.241 | 0.189 | Aldehyde oxidase inhibitor | 0.153 0.136 DBMET02689 0.164 0.127 DBMET02691 0.189 0.111 DBMET02692 | DBMET02692 | |
| 0.026 | 0.185 | 0.088 | Porphobilinogen synthase inhibitor | 0.088 0.042 DBMET02694 | DBMET02694 | |
| 0.074 | 0.236 | 0.135 | Farnesoid X receptor antagonist | 0.121 0.102 DBMET02691 0.135 0.074 DBMET02693 0.117 0.112 DBMET02692 | DBMET02693 | |
| 0.124 | 0.289 | 0.274 | Peptidyltransferase inhibitor | 0.166 0.155 DBMET02688 0.19 0.112 DBMET02689 0.274 0.036 DBMET02690 0.163 0.162 DBMET02691 0.189 0.113 DBMET02693 0.163 0.162 DBMET02694 | DBMET02690 | |
| 0.124 | 0.29 | 0.185 | Nootropic | 0.185 0.179 DBMET02689 | DBMET02689 | |
| 0.022 | 0.188 | 0.082 | Cathepsin D inhibitor | 0.082 0.024 DBMET02689 | DBMET02689 | |
| 0.052 | 0.219 | 0.106 | Caspase 3 inhibitor | 0.106 0.082 DBMET02694 | DBMET02694 | |
| 0.066 | 0.238 | 0.109 | Protein kinase stimulant | 0.109 0.106 DBMET02688 | DBMET02688 | |
| 0.079 | 0.254 | 0.157 | GABA C receptor rho-2 antagonist | 0.157 0.064 DBMET02688 | DBMET02688 | |
| 0.024 | 0.207 | 0.05 | Thromboxane synthase inhibitor | 0.05 0.047 DBMET02694 | DBMET02694 | |
| 0.021 | 0.207 | 0.157 | NMDA 2B receptor antagonist | 0.157 0.008 DBMET02690 | DBMET02690 | |
| 0.135 | 0.323 | 0.269 | Caspase 3 stimulant | 0.192 0.181 DBMET02691 0.269 0.097 DBMET02692 | DBMET02692 | |
| 0.022 | 0.213 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.043 DBMET02688 | DBMET02688 | |
| 0.016 | 0.214 | 0.057 | Cyclin A1 inhibitor | 0.057 0.044 DBMET02688 | DBMET02688 | |
| 0.082 | 0.281 | 0.22 | Tumour necrosis factor alpha release inhibitor | 0.177 0.128 DBMET02689 0.22 0.093 DBMET02692 | DBMET02692 | |
| 0.017 | 0.217 | 0.04 | AICAR transformylase inhibitor | 0.04 0.038 DBMET02694 | DBMET02694 | |
| 0.017 | 0.218 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | 0.046 0.043 DBMET02688 | DBMET02688 | |
| 0.017 | 0.222 | 0.046 | Phenylethanolamine N methyltransferase inhibitor | 0.046 0.019 DBMET02688 | DBMET02688 | |
| 0.006 | 0.215 | 0.029 | Prostacyclin antagonist | 0.029 0.027 DBMET02694 | DBMET02694 | |
| 0.036 | 0.245 | 0.088 | ATPase (Vacuolar H+) inhibitor | 0.088 0.061 DBMET02692 | DBMET02692 | |
| 0.044 | 0.26 | 0.155 | Lipid peroxidase inhibitor | 0.118 0.096 DBMET02691 0.155 0.065 DBMET02692 | DBMET02692 | |
| 0.005 | 0.223 | 0.029 | Nicotinic alpha3beta4 receptor agonist | 0.029 0.022 DBMET02688 | DBMET02688 | |
| 0.033 | 0.253 | 0.062 | Caspase 9 inhibitor | 0.062 0.043 DBMET02694 | DBMET02694 | |
| 0.052 | 0.278 | 0.153 | Angiogenesis stimulant | 0.136 0.131 DBMET02693 0.153 0.12 DBMET02694 | DBMET02694 | |
| 0.114 | 0.342 | 0.153 | MAP kinase kinase 5 inhibitor | 0.153 0.142 DBMET02688 | DBMET02688 | |
| 0.05 | 0.284 | 0.126 | Estrogen antagonist | 0.126 0.045 DBMET02691 | DBMET02691 | |
| 0.147 | 0.384 | 0.226 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.226 0.103 DBMET02688 | DBMET02688 | |
| 0.017 | 0.254 | 0.049 | Aconitate hydratase inhibitor | 0.049 0.041 DBMET02694 | DBMET02694 | |
| 0.018 | 0.261 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.057 DBMET02688 | DBMET02688 | |
| 0.035 | 0.292 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.088 DBMET02688 | DBMET02688 | |
| 0.079 | 0.341 | 0.141 | Lipocortins synthesis antagonist | 0.141 0.119 DBMET02694 | DBMET02694 | |
| 0.083 | 0.349 | 0.217 | 12-Lipoxygenase inhibitor | 0.217 0.133 DBMET02692 | DBMET02692 | |
| 0.051 | 0.32 | 0.115 | Interleukin 4 antagonist | 0.115 0.094 DBMET02692 | DBMET02692 | |
| 0.087 | 0.357 | 0.2 | DNA synthesis inhibitor | 0.2 0.124 DBMET02688 | DBMET02688 | |
| 0.055 | 0.328 | 0.149 | Hypolipemic | 0.149 0.137 DBMET02689 | DBMET02689 | |
| 0.054 | 0.331 | 0.114 | Folate antagonist | 0.114 0.045 DBMET02694 | DBMET02694 | |
| 0.114 | 0.391 | 0.207 | Calcium channel activator | 0.207 0.203 DBMET02690 | DBMET02690 | |
| 0.033 | 0.336 | 0.11 | Estrogen receptor beta antagonist | 0.11 0.046 DBMET02691 | DBMET02691 | |
| 0.105 | 0.408 | 0.255 | Apoptosis antagonist | 0.202 0.176 DBMET02692 0.255 0.123 DBMET02694 | DBMET02694 | |
| 0.014 | 0.341 | 0.065 | Myc inhibitor | 0.065 0.023 DBMET02688 | DBMET02688 | |
| 0.054 | 0.388 | 0.19 | Vasodilator | 0.19 0.112 DBMET02690 | DBMET02690 | |
| 0.038 | 0.375 | 0.197 | Amyloid beta aggregation inhibitor | 0.197 0.079 DBMET02692 | DBMET02692 | |
| 0.037 | 0.388 | 0.135 | Cell wall synthesis inhibitor | 0.135 0.08 DBMET02690 | DBMET02690 | |
| 0.045 | 0.436 | 0.178 | Insulin secretagoues | 0.178 0.049 DBMET02689 | DBMET02689 | |
| 0.072 | 0.489 | 0.163 | Catenin beta inhibitor | 0.163 0.079 DBMET02694 | DBMET02694 | |
| 0.01 | 0.436 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.013 DBMET02693 | DBMET02693 | |
| 0.018 | 0.447 | 0.163 | Bronchodilator | 0.163 0.027 DBMET02690 | DBMET02690 | |
| 0.03 | 0.536 | 0.211 | Antioxidant | 0.211 0.107 DBMET02692 | DBMET02692 | |
| 0.027 | 0.565 | 0.128 | MAP3K9 inhibitor | 0.128 0.098 DBMET02693 | DBMET02693 | |
| 0.004 | 0.568 | 0.05 | 5 Hydroxytryptamine 2C agonist | 0.05 0.028 DBMET02688 | DBMET02688 | |
| 0.015 | 0.619 | 0.206 | Free radical scavenger | 0.206 0.093 DBMET02692 | DBMET02692 | |
| 0.042 | 0.679 | 0.237 | Apoptosis agonist | 0.237 0.229 DBMET02692 | DBMET02692 | |
| 0.006 | 0.711 | 0.116 | Tubulin antagonist | 0.116 0.084 DBMET02692 | DBMET02692 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |